New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
319.42+4.25 (+1.35%)
At close: 04:00PM EDT
318.78 -0.64 (-0.20%)
After hours: 06:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.98B
Enterprise value 8.74B
Trailing P/E N/A
Forward P/E 29.33
PEG ratio (5-yr expected) 1.19
Price/sales (ttm)3.55
Price/book (mrq)1.01
Enterprise value/revenue 3.35
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-21.20%
S&P500 52-week change 318.96%
52-week high 3419.00
52-week low 3261.59
50-day moving average 3289.49
200-day moving average 3307.97

Share statistics

Avg vol (3-month) 3256.95k
Avg vol (10-day) 3235.59k
Shares outstanding 523.45M
Implied shares outstanding 628.58M
Float 819.97M
% held by insiders 115.20%
% held by institutions 182.55%
Shares short (15 Jul 2024) 41.42M
Short ratio (15 Jul 2024) 44.27
Short % of float (15 Jul 2024) 47.96%
Short % of shares outstanding (15 Jul 2024) 44.98%
Shares short (prior month 14 Jun 2024) 4867.52k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 308 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -12.37%
Operating margin (ttm)8.48%

Management effectiveness

Return on assets (ttm)1.69%
Return on equity (ttm)-3.43%

Income statement

Revenue (ttm)2.61B
Revenue per share (ttm)90.02
Quarterly revenue growth (yoy)-9.80%
Gross profit (ttm)N/A
EBITDA 502.99M
Net income avi to common (ttm)-322.37M
Diluted EPS (ttm)-10.70
Quarterly earnings growth (yoy)456.70%

Balance sheet

Total cash (mrq)1.65B
Total cash per share (mrq)57.69
Total debt (mrq)1.4B
Total debt/equity (mrq)15.47%
Current ratio (mrq)6.57
Book value per share (mrq)317.32

Cash flow statement

Operating cash flow (ttm)346.57M
Levered free cash flow (ttm)120.82M